Lv1
40 积分 2026-01-10 加入
Safety and Efficacy of Anti-CD19/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor-Natural Killer Cell (CAR-NK) Therapy in Pediatric Patients with Refractory Systemic Lupus Erythematosus (SLE): A Preliminary Clinical Study
8天前
已完结
Safety and Efficacy of Anti-CD19/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor-Natural Killer Cell (CAR-NK) Therapy in Pediatric Patients with Refractory Systemic Lupus Erythematosus (SLE): A Preliminary Clinical Study
8天前
已关闭
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
8天前
已完结
[Research progress of traditional Chinese medicine formula in treating allergic rhinitis]
9天前
已完结
B cell-targeted therapies in systemic lupus erythematosus: Current status and perspectives
1个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
1个月前
已完结
Cytokine-induced memory-like natural killer cells in systemic lupus erythematosus patients
1个月前
已完结
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
1个月前
已完结
Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus
2个月前
已完结
皖公网安备34019202002308
